Valeant Pharmaceuticals North America

25 recalls β€’ β€’ Categories: Prescription Drugs, Over-the-Counter, Other Drugs, Other Medical Devices

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details β†’

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details β†’

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details β†’

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details β†’

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details β†’

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Aug 24, 2018 Over-the-Counter View Details β†’

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Aug 24, 2018 Over-the-Counter View Details β†’

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Aug 24, 2018 Over-the-Counter View Details β†’

Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.

Jul 10, 2018 Prescription Drugs Nationwide View Details β†’

Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

Jun 28, 2017 Prescription Drugs Nationwide View Details β†’

Discoloration.

Mar 20, 2017 Other Drugs Nationwide View Details β†’

Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.

May 23, 2016 Prescription Drugs Nationwide View Details β†’

Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

Dec 31, 2014 Prescription Drugs Nationwide View Details β†’

Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.

May 21, 2014 Prescription Drugs Nationwide View Details β†’